KCPG
CTSO icon

Kavar Capital Partners Group’s Cytosorbents Corp CTSO Stock Holding History

Kavar Capital Partners Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-250
Closed -$2K – 202
2019
Q2 		$2K Buy
+250
New +$1.72K ﹤0.01% 467
2018
Q3 		– Sell
-250
Closed -$3K – 159
2018
Q2 		$3K Hold
250
– – ﹤0.01% 390
2018
Q1 		$2K Buy
+250
New +$1.89K ﹤0.01% 404

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Kavar Capital Partners Group's CTSO Position: Q3 2019 in Review

Kavar Capital Partners Group sold out of Cytosorbents Corp (CTSO) in Q3 2019, closing a stake of 250 shares — an estimated $2K sold.

Kavar Capital Partners Group first reported a position in CTSO in Q1 2018 and held it in 3 quarters. The position peaked at $3K in Q2 2018. 69 funds tracked by Wall St. Rank hold CTSO as of Q3 2019.

  • Kavar Capital Partners Group reported no remaining Cytosorbents Corp position as of Q3 2019 after selling out during the quarter.
  • Kavar Capital Partners Group sold 250 Cytosorbents Corp shares in Q3 2019, an estimated $2K.
  • Kavar Capital Partners Group first reported a position in Cytosorbents Corp in Q1 2018 and held it in 3 quarters.
  • Kavar Capital Partners Group's Cytosorbents Corp position peaked at $3K in Q2 2018.
  • 69 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2019.

Based on Kavar Capital Partners Group's 13F filing for Q3 2019, filed 12 Nov 2019.